EKF Diagnostics HoldingsEKDHF 54 PB Ratio is 1.63 as of Jul. 13, 2026, which is 17% below its 10-year median of 1.97. GuruFocus rates EKDHF with a GF Score™ of 54/100 and a GF Value™ of $0.36 (Fairly Valued). The stock has 4 warning signs investors should review. Among 788 Medical Devices & Instruments companies, EKF Diagnostics Holdings ranks better than 61.04% on this metric.
The historical rank and industry rank for EKF Diagnostics Holdings's PB Ratio or its related term are showing as below:
EKDHF'
s PB Ratio Range Over the Past 10 Years
Min: 1.23 Med: 1.97 Max: 4.95
Current: 1.6
During the past 13 years, EKF Diagnostics Holdings's highest PB Ratio was 4.95. The lowest was 1.23. And the median was 1.97.
EKDHF's PB Ratio is ranked better than 61.04% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.055
vs EKDHF: 1.60
During the past 3 years, the average Book Value Per Share Growth Rate was -0.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -3.30% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 3.30% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of EKF Diagnostics Holdings was 110.30% per year. The lowest was -14.00% per year. And the median was 2.15% per year.
Back to Basics: PB Ratio
EKF Diagnostics Holdings (OTCPK:EKDHF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, EKF Diagnostics Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EKF Diagnostics Holdings PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, EKF Diagnostics Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where EKF Diagnostics Holdings's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
EKF Diagnostics Holdings (EKDHF) has a PB Ratio of 1.63 as of Jul. 13, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on EKF Diagnostics Holdings and its competitors. This is 17% below median its historical median of 1.97. Over the past decade, EKF Diagnostics Holdings' PB Ratio has ranged from 1.23 to 4.95. According to the industry distribution chart, EKF Diagnostics Holdings ranks #307 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 39%.
Is EKF Diagnostics Holdings' PB Ratio too high?
EKF Diagnostics Holdings' current PB Ratio of 1.63 is 17% below median its 10-year median of 1.97. Over the past 10 years, this metric has ranged from a low of 1.23 to a high of 4.95. The Medical Devices & Instruments industry median PB Ratio is 2.06. EKF Diagnostics Holdings' value of 1.63 is 20.7% below this industry median. Based on the distribution chart, EKF Diagnostics Holdings ranks #307 out of 788 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, EKF Diagnostics Holdings has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EKF Diagnostics Holdings' PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, EKF Diagnostics Holdings ranks #307 out of 788 companies for PB Ratio. This puts EKF Diagnostics Holdings in the upper half of its industry. The industry median PB Ratio is 2.06. EKF Diagnostics Holdings' value of 1.63 is 20.7% below this benchmark. Historically, EKF Diagnostics Holdings' own PB Ratio has ranged from 1.23 to 4.95 over the past decade. While the company's 10-year median is 1.97 vs. the industry median of 2.06, EKF Diagnostics Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.06, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EKF Diagnostics Holdings's current PB Ratio of 1.63 is 20.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on EKF Diagnostics Holdings and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EKF Diagnostics Holdings's current PB Ratio is 1.63, which is 17% below median its own 10-year median of 1.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EKF Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, EKF Diagnostics Holdings (EKDHF) is currently considered Fairly Valued. The stock's GF Value™ is $0.36, compared to a current price of $0.35 — trading 3.6% below its estimated fair value. The current PB Ratio is 1.63, which is 17% below median its 10-year median of 1.97 and 20.7% below the Medical Devices & Instruments industry median of 2.06. EKF Diagnostics Holdings' overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For EKF Diagnostics Holdings (EKDHF), the current PB Ratio is 1.63 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EKF Diagnostics Holdings (EKDHF) Overvalued in 2026?
Based on GuruFocus' analysis, EKF Diagnostics Holdings stock appears to be undervalued.
The current stock price of $0.35 is trading 3.6% below its estimated GF Value™ of $0.36.
GuruFocus considers EKF Diagnostics Holdings to be Fairly Valued.
Key valuation signals for EKDHF:
PB Ratio: 1.63 (17% below median its 10-year median of 1.97)
GF Value™: $0.36 vs. price of $0.35 (3.6% below fair value)
Industry Position: 20.7% below the Medical Devices & Instruments median (#307 of 788)
No single metric tells the full story. See the EKDHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EKF Diagnostics Holdings PLC is engaged in development, manufacture and supply of products and services into the in-vitro diagnostic (IVD) market place. The Group has presence in the UK, USA, Germany, and Russia, and sells throughout the world including Europe, the Middle East, the Americas, Asia, and Africa. It derive their revenue from the manufacture and sale of medical diagnostic equipment and reagents. Other services include the servicing and distribution of third party company products under separate distribution agreements.
54GF Score
Get the complete analysis for EKDHF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EKDHF has been successfully added to your 
